Whitepapers

All Case Studies Views Resources Whitepapers Podcasts On-Demand Webinars
Comparing Outcomes Pre- and Post-Cancer Drugs Fund
In this paper we look at the 18 appraisals that had entered and exited the CDF between June 2016 and April 2022 to provide insights on what manufacturers can expect from the CDF and to understand whether the CDF is operating optimally to resolve genuine uncertainty in submissions.
Whitepaper Oct 19, 2022
The Power of the Patient
In this paper, we aim to define the different types of burden of illness studies and highlight the importance of qualitative burden of illness studies as complementary to patient reported outcomes data, and as separate stand-alone research projects that can further support HTA committees in their decision-making.
Whitepaper Jul 14, 2022